MedicinesFAQ

Levilimab Uses, Dosage, Side Effects and more

Levilimab is under investigation in clinical trial NCT04227366 (Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis).

Attribute Details
Trade Name Levilimab
Generic Levilimab
Levilimab Other Names Levilimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am
   

How Levilimab works

Levilimab is an IL-6 inhibitor originally developed to treat rheumatoid arthiritis. Its actions at IL-6 help augment cytokine storm effects, reducing inflammation.

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.